Krishna Suri

416 total citations
9 papers, 335 citations indexed

About

Krishna Suri is a scholar working on Molecular Biology, Biomaterials and Pharmacology. According to data from OpenAlex, Krishna Suri has authored 9 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Biomaterials and 2 papers in Pharmacology. Recurrent topics in Krishna Suri's work include Nanoparticle-Based Drug Delivery (3 papers), Natural product bioactivities and synthesis (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Krishna Suri is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Natural product bioactivities and synthesis (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Krishna Suri collaborates with scholars based in India, Italy and United States. Krishna Suri's co-authors include Massimo Fresta, Mauro Ferrari, Christian Celia, Joy Wolfram, Haifa Shen, Sarang Bani, Yuliang Zhao, Naresh K. Satti, Jianliang Shen and Ghulam N. Qazi and has published in prestigious journals such as Colloids and Surfaces B Biointerfaces, Pharmacological Research and Phytotherapy Research.

In The Last Decade

Krishna Suri

9 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Krishna Suri India	8	180	98	51	44	43	9	335
Yiping Guo China	12	141 0.8×	75 0.8×	66 1.3×	43 1.0×	24 0.6×	27	390
Sang Gon Lee South Korea	8	205 1.1×	129 1.3×	64 1.3×	26 0.6×	27 0.6×	13	392
Jianli Liu China	15	271 1.5×	112 1.1×	41 0.8×	35 0.8×	26 0.6×	45	591
Qiufang Zhang China	13	149 0.8×	68 0.7×	27 0.5×	35 0.8×	21 0.5×	26	419
Alex E. Grill United States	10	144 0.8×	116 1.2×	45 0.9×	31 0.7×	29 0.7×	13	394
Xiaoyu Lin China	8	95 0.5×	101 1.0×	79 1.5×	38 0.9×	23 0.5×	17	331
Fengjie Liu China	12	190 1.1×	76 0.8×	63 1.2×	34 0.8×	47 1.1×	40	396
Vasanth Raj Palanimuthu India	11	172 1.0×	60 0.6×	40 0.8×	14 0.3×	26 0.6×	20	402
Jihui Lu China	10	103 0.6×	113 1.2×	96 1.9×	45 1.0×	26 0.6×	23	378
Rinku Baishya India	12	164 0.9×	102 1.0×	53 1.0×	18 0.4×	20 0.5×	31	412

Countries citing papers authored by Krishna Suri

Since Specialization

Citations

This map shows the geographic impact of Krishna Suri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Suri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Suri more than expected).

Fields of papers citing papers by Krishna Suri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna Suri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Suri. The network helps show where Krishna Suri may publish in the future.

Co-authorship network of co-authors of Krishna Suri

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna Suri. A scholar is included among the top collaborators of Krishna Suri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna Suri. Krishna Suri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Wolfram, Joy, Bronwyn Scott, Kathryn Boom, et al.. (2016). Hesperetin Liposomes for Cancer Therapy. Current Drug Delivery. 13(5). 711–719. 45 indexed citations

2.

Wolfram, Joy, Krishna Suri, Yi Huang, et al.. (2014). Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells. Journal of Microencapsulation. 31(5). 501–507. 66 indexed citations

3.

Wolfram, Joy, Krishna Suri, Yong Yang, et al.. (2013). Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids and Surfaces B Biointerfaces. 114. 294–300. 100 indexed citations

4.

Satti, N.K., et al.. (2011). Ameliorating effects of aqueous fraction of Bidens pilosa against acute and chronic inflammation with reference to changes in proinflammatory mediators and T cells.. Journal of Pharmacy Research. 4(3). 917–921. 1 indexed citations

5.

Pandey, Anjali, Sarang Bani, Krishna Suri, et al.. (2009). Amelioration of adjuvant induced arthritis by apocynin. Phytotherapy Research. 23(10). 1462–1468. 17 indexed citations

6.

Gupta, Manju Lata, et al.. (2009). Podophyllum hexandrum‐Mediated Survival Protection and Restoration of Other Cellular Injuries in Lethally Irradiated Mice. Evidence-based Complementary and Alternative Medicine. 2011(1). 175140–175140. 23 indexed citations

7.

Pandey, Anjali, Sarang Bani, Prabhu Dutt, & Krishna Suri. (2009). Modulation of Th1/Th2 cytokines and inflammatory mediators by hydroxychavicol in adjuvant induced arthritic tissues. Cytokine. 49(1). 114–121. 12 indexed citations

8.

Bani, Sarang, et al.. (2007). Immunomodulation exhibited by piperinic acid through suppression of proinflammatory cytokines. International Immunopharmacology. 7(7). 889–899. 15 indexed citations

9.

Ahmad, Sheikh F., Beenish Khan, Sarang Bani, et al.. (2006). Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production. Pharmacological Research. 53(3). 233–240. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact